Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis
Top Cited Papers
Open Access
- 1 August 2004
- Vol. 53 (8) , 1096-1101
- https://doi.org/10.1136/gut.2003.021154
Abstract
Background and aims: The incidence of irritable bowel syndrome (IBS) or functional bowel disorders (FBD) after bacillary dysentery (BD) has not been extensively evaluated, and little is known of the pathogenesis of post-infective (PI) IBS. Therefore, we investigated the incidence of IBS and FBD in a Chinese patient population who had recovered from BD. To further elucidate its pathogenesis, neuroimmunological changes, including interleukins (IL), mast cells, neuropeptides, and the relationship between mast cells and intestinal nerves, were investigated. Methods: A cohort study of 295 patients who had recovered from BD (shigella identified from stool in 71.4%) and 243 control subjects consisting of patient siblings or spouses who had not been infected with BD were included in the study. All subjects were followed up using questionnaires for 1–2 years to explore the incidence of FBD and IBS, as defined by the Rome II criteria. In 56 cases of IBS (PI and non-PI) from another source, the number of mast cells in biopsy specimens from the intestinal mucosa were stained with antitryptase antibody and counted under light microscopy. Also, the relationship of mast cells to neurone specific enolase (NSE), substance P (SP), 5-hydroxytryptamine (5-HT), or calcitonin gene related peptide positive nerve fibres was observed using double staining with alcian blue and neuropeptide antibodies. In 30 cases of IBS (PI-IBS, n = 15) taken at random from the 56 cases, expression of interleukin (IL)-1α, IL-1β, and IL-1 receptor antagonist (IL-1ra) mRNAs in intestinal mucosa were identified using reverse transcription-polymerase chain reaction. The above results were compared with 12 non-IBS controls. Results: In the BD infected cohort, the incidences of FBD and IBS were 22.4% and 8.1% (in total)–10.2% (among those in who shigella were identified) respectively, which were significantly higher (pConclusions: BD is a causative factor in PI-IBS. The immune and nervous system may both play important roles in the pathogenesis of PI-IBS.Keywords
This publication has 21 references indexed in Scilit:
- Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndromeGut, 2003
- Cosensitivity of vagal mucosal afferents to histamine and 5-HT in the rat jejunumAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2002
- Neuropathophysiology of Irritable Bowel SyndromeJournal of Clinical Gastroenterology, 2002
- Activation of the mucosal immune system in irritable bowel syndromeGastroenterology, 2002
- Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndromeGut, 2000
- Epidemiologic study of the irritable bowel syndrome in Beijing: stratified randomized study by cluster sampling.2000
- Interleukin-1 beta inhibits the intestinal transport of [14C] 3-O-methylglucose in the ratLife Sciences, 1998
- Psychometric scores and persistence of irritable bowel after infectious diarrhoeaThe Lancet, 1996
- Impaired sympathetic nerve function in the inflamed rat intestineGastroenterology, 1991
- Interleukin-1β as a potent hyperalgesic agent antagonized by a tripeptide analogueNature, 1988